Pneumopathy to thalidomide

H. Afif, N. Benouhoud, A. Aichane, Z. Bouayad (Casablanca, Morocco)

Source: Annual Congress 2006 - Clinical management of interstitial lung disease
Session: Clinical management of interstitial lung disease
Session type: E-Posters in free access
Number: 640
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Afif, N. Benouhoud, A. Aichane, Z. Bouayad (Casablanca, Morocco). Pneumopathy to thalidomide. Eur Respir J 2006; 28: Suppl. 50, 640

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Immunoallergic manifestations of antituberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 505s
Year: 2006

Combination of pentoxifylline and steroids in sarcoidosis treatment
Source: Eur Respir J 2005; 26: Suppl. 49, 269s
Year: 2005

Idiopathic pulmonary fibrosis: efficacy of complex immunosuppressive therapy by cyclophosphamide and corticosteroids
Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease
Year: 2009

Combined cytotoxic treatment (methotrexate and cyclophosphamide) in association with prednisone in sarcoidosis
Source: Eur Respir J 2004; 24: Suppl. 48, 713s
Year: 2004

Azathioprine and low-dose prednisone in chronic pulmonary sarcoidosis
Source: Eur Respir J 2005; 26: Suppl. 49, 268s
Year: 2005

Pulmonary toxicity during chemotherapy with etopiside and carboplatin
Source: Eur Respir J 2003; 22: Suppl. 45, 64s
Year: 2003

Methotrexate vs azathioprine in chronic sarcoidosis
Source: Annual Congress 2012 - Sarcoidosis
Year: 2012

Therapy with low dose methotrexate plus diprospan in patient with recalcitrant recidivating sarcoidosis
Source: Eur Respir J 2006; 28: Suppl. 50, 541s
Year: 2006

Immunomodulating activity of inhalations of ultra-low doses of alkylating drug melphalan for severe bronchial asthma treatment
Source: Eur Respir J 2004; 24: Suppl. 48, 580s
Year: 2004

Colchicine, prednisone versus no therapy in idiopathic pulmonary fibosis
Source: Eur Respir J 2006; 28: Suppl. 50, 744s
Year: 2006

Pulmonary toxicity after long-term treatment with lenalidomide in two myeloma patients
Source: Eur Respir Rev 2013; 22: 93-95
Year: 2013


Antituberculosis chemotherapy toxicity reduction
Source: Annual Congress 2012 - Tuberculosis: clinical findings III
Year: 2012

Treatment of sarcoidosis – pentoxifylline
Source: International Congress 2019 – Granulomatous disorders: pathogenesis, epidemiology and clinical issues
Year: 2019

Evaluation of antituberculous drugs administration
Source: Eur Respir J 2002; 20: Suppl. 38, 547s
Year: 2002

Safety and efficacy of prolonged treatment of fibrosing alveolitis in scleroderma with cyclophosphamide
Source: Eur Respir J 2005; 26: Suppl. 49, 266s
Year: 2005

High-doses glucocorticosteroid treatment in sarcoidosis patients
Source: Eur Respir J 2007; 30: Suppl. 51, 118s
Year: 2007

Etiology and etiotropic therapy of angiogenic sepsis
Source: Eur Respir J 2003; 22: Suppl. 45, 452s
Year: 2003

Rifamycin induced leukocytoclastic vasculitis. A rare side-effect of anti-tuberculous chemotherapy
Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe
Year: 2016

Hepatotoxicity due to antituberculosis drug treatment
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis II
Year: 2008

High pulse dose steroids in Severe COVID-19 pneumonitis refractory hypoxemia to dexamethasone
Source: Virtual Congress 2021 – Highlights in COVID-19 diagnosis and treatment
Year: 2021